🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate efficacy and safety of Dextenza fo...
Status
Completed
Location
Retina Vitreous Surgeons of Central New York, PC
Start Date
2020-01-03
Trial ID
NCT04462523
Treatments Being Tested
To assess the safety and efficacy of PACK-CXL (photoactivated chromophore f...
Status
Completed
Location
University of Geneva
Start Date
2016-03
Trial ID
NCT02717871
Treatments Being Tested
The aim of this study is to assess visual and refractive outcomes after Tor...
Status
Completed
Location
Eye Hospital Pristina
Start Date
2018-06-01
Trial ID
NCT04468022
Treatments Being Tested
To determine patient preference and treatment outcomes with an intracanalic...
Status
Completed
Location
Vance Thompson Vision
Start Date
2020-06-08
Trial ID
NCT04396990
Treatments Being Tested
After implantation of an Ahmed glaucoma valve in patients with glaucoma, hy...
Status
Unknown
Location
Credit Valley Eye Care
Start Date
2012-02
Trial ID
NCT01535768
Treatments Being Tested
Purpose: Study the effect of nepafenac ophthalmic suspension 0.1% to preven...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2007-06
Trial ID
NCT00494494
Treatments Being Tested
Cataract surgery is the most common surgical procedure performed on humans ...
Status
Completed
Location
The Eye Institute of West Florida
Start Date
2020-02-20
Trial ID
NCT04781335
Treatments Being Tested
To demonstrate that intraoperative use of subtenon triamcinolone acetonide ...
Status
Recruiting
Location
Massachusetts Eye and Ear
Start Date
2022-07-25
Trial ID
NCT05331664
To evaluate the clinical outcomes with optometrist pre-surgical insertion o...
Status
Completed
Location
Vance Thompson Vision
Start Date
2021-08-23
Trial ID
NCT05023304
Treatments Being Tested
The use of topical beta-blockers, such as 0.25% timolol, in promoting wound...
Status
Completed
Location
Mohs and Dermatologic Surgery Center, Brigham and Women's Hospital
Start Date
2018-08-20
Trial ID
NCT03452072
Treatments Being Tested